Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer to provide new vaccine to developing nations

Pfizer to provide new vaccine to developing nations

24th March 2010

Pfizer has agreed to supply its pneumococcal disease vaccine to some of the poorest countries in the world as part of an international scheme.

The company is to participate in the Advance Market Commitment (AMC) pilot project by offering discounted supplies of Prevenar 13 for children in a ten-year provisional supply agreement.

This scheme has been arranged in cooperation with Unicef and with the support of the Global Alliance for Vaccines and Immunisation (GAVI), which helps to pay the cost of the vaccines in association with the AMC donor fund.

In addition, the long-term nature of Pfizer’s agreement helps to ensure that the vaccine will remain affordable after the donor contributions are exhausted.

Jeffrey Kindler, chairman and chief executive officer of Pfizer, said: “Pfizer is dedicated to broadening access around the world to our medicines and public-private partnerships such as the one involving the AMC are critical to achieving true inroads on this front.”

The company published phase III clinical trial results of Prevenar 13 last week which demonstrated the vaccine’s immunogenicity.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.